New cancer drug WBC100 tested in early trial – but no cure yet
Disease control
Terminated
This early-phase study tested a new drug called WBC100 in 68 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and find the right dose, not to cure the cancer. The study was stopped early, so results are limite…
Phase: PHASE1 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC